Trial Profile
Phase 3 study of Relday
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 16 May 2016
Price :
$35
*
At a glance
- Drugs Risperidone (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- 16 May 2016 New trial record